Mesoblast's Mesenchymal Precursor Cells Induce Functional Recovery in Ischemic Stroke Model
11 nov. 2013 06h00 HE
|
Mesoblast
NEW YORK and MELBOURNE, Australia, Nov. 11, 2013 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX:MSB) (USOTC:MBLTY) today announced positive preclinical trial results which...